Hemopericardium in a Sirolimus-Treated Renal Transplant Patient

被引：0
|
作者：
Groudan, Kevin [1 ]
Sawalha, Khalid [2 ]
Bhat, Anusha G. [1 ]
Eltanbedawi, Ahmed [1 ]
Ambesh, Paurush [3 ]
机构：
[1] Baystate Med Ctr, Internal Med, Springfield, MA 01199 USA
[2] Univ Massachusetts, Med Sch Baystate, Internal Med, Springfield, MA USA
[3] Univ Massachusetts, Med Sch Baystate, Cardiovasc Med, Springfield, MA USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2020年 / 12卷 / 08期
关键词：
hemopericardium; sirolimus; renal transplant; immunosuppression; LYMPHEDEMA;
D O I：
10.7759/cureus.9508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be reported in the literature. We report the first case of sirolimus-induced hemopericardium in a renal transplant patient.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Sirolimus: dyslipidaemia in renal transplant recipients
    Reactions Weekly, 2003, 968 (1) : 4 - 4
  • [42] Hemopericardium and Cardiac Tamponade in a Patient Treated with Dabigatran Etexilate
    Ktzilirmak, Filiz
    Gunes, Haci Murat
    Guler, Ekrem
    Demir, Gultekin Gunhan
    Karaca, Oguz
    Canpolat, Habibe Gamze
    KOREAN CIRCULATION JOURNAL, 2016, 46 (01) : 99 - 101
  • [43] Renal dysfunction in a renal transplant patient treated concurrently with cyclosporine and imatinib
    Karen E. Mulder
    Merrill J. Egorin
    Michael B. Sawyer
    Investigational New Drugs, 2012, 30 : 2400 - 2402
  • [44] Renal dysfunction in a renal transplant patient treated concurrently with cyclosporine and imatinib
    Mulder, Karen E.
    Egorin, Merrill J.
    Sawyer, Michael B.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2400 - 2402
  • [45] T cell function monitoring in stable renal transplant patients treated with sirolimus monotherapy
    Brunet, Merce
    Campistol, Josep M.
    Diekmann, Fritz
    Guillen, David
    Millan, Olga
    TRANSPLANT INTERNATIONAL, 2007, 20 : 117 - 117
  • [46] Renal function in lung and heart-lung transplant recipients treated with sirolimus.
    Goldberg, HJ
    Ibrahim, HN
    Hertz, MI
    Savik, K
    Dunitz, JM
    Whelan, TPM
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 345 - 345
  • [47] Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients
    Kahan, BD
    Yakupoglu, YK
    Schoenberg, L
    Knight, RJ
    Katz, SM
    Lai, D
    Van Buren, CT
    TRANSPLANTATION, 2005, 80 (06) : 749 - 758
  • [48] An uncommon case of spontaneous hemopericardium in a patient treated with rivaroxaban
    Ioppolo, Anna Maria
    Longobardo, Luca
    D'Isa, Salvatore
    De Gregorio, Paola
    Manfredi, Mariella
    De Cesare, Nicoletta Bianca
    JOURNAL OF CARDIOVASCULAR ECHOGRAPHY, 2019, 29 (04) : 180 - 182
  • [49] An atypical form of sirolimus-associated interstitial pneumonitis in a renal transplant patient.
    Champion, L
    Morelon, E
    Rerolle, JP
    Stern, M
    Peraldi, MN
    Kreis, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 920A - 920A
  • [50] SIROLIMUS-INDUCED IMMUNE MEDIATED TOXIC DEMYELINATING POLYRADICULONEUROPATHY IN A RENAL TRANSPLANT PATIENT
    Kalindu, Muthucumarana
    Kevin, O'Connor
    David, Nolan
    Mina, John
    Ramyasuda, Swaminathan
    Wai, Leong
    Ashley, Irish
    IMMUNOLOGY AND CELL BIOLOGY, 2014, 92 (08): : A18 - A18
12345